Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues XPER Q1 2026 Earnings Strong EPS Beat Drives Stock Higher TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued RD Focus PHR Q1 2026 Earnings EPS Falls Short by 59 Stock Edges Higher WTFCN Q1 2026 Earnings EPS Exceeds Expectations by 613 Despite Flat Stock Reaction